10 insiders reported 66 Form 4 transactions for Immunome Inc. (IMNM) over the past 18 months (most recent 2026-09-15). Recent activity: Higgins Jack (Chief Scientific Officer) Sell 13,200 shares, Higgins Jack (Chief Scientific Officer) Buy 18,000 shares, Higgins Jack (Chief Scientific Officer) Sell 8,800 shares, Barchas Isaac (Director) Sell 10,125 shares, Barchas Isaac (Director) Sell 62,291 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Higgins Jack | Chief Scientific Officer | Sell | 13,200 | $334,224 |
| 2026-09-15 | Higgins Jack | Chief Scientific Officer | Buy | 18,000 | $24,300 |
| 2026-09-15 | Higgins Jack | Chief Scientific Officer | Sell | 8,800 | $0 |
| 2026-08-12 | Barchas Isaac | Director | Sell | 10,125 | $263,959 |
| 2026-08-12 | Barchas Isaac | Director | Sell | 62,291 | $1.6M |
| 2026-08-12 | Barchas Isaac | Director | Sell | 11,048 | $301,058 |
| 2026-08-10 | Barchas Isaac | Director | Sell | 20,840 | $543,090 |
| 2026-08-10 | Barchas Isaac | Director | Sell | 15,248 | $397,363 |
| 2026-08-06 | Horn Kinney | CHIEF BUSINESS OFFICER | Buy | 50,366 | $650,729 |
| 2026-08-06 | Horn Kinney | CHIEF BUSINESS OFFICER | Buy | 40,250 | $426,650 |
| 2026-08-06 | Horn Kinney | CHIEF BUSINESS OFFICER | Sell | 90,616 | $2.3M |
| 2026-07-27 | Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | Buy | 38,250 | $0 |
| 2026-07-27 | SIEGALL CLAY B | President and CEO | Buy | 180,000 | $0 |
| 2026-07-27 | Horn Kinney | CHIEF BUSINESS OFFICER | Buy | 31,250 | $0 |
| 2026-07-27 | Higgins Jack | Chief Scientific Officer | Buy | 38,250 | $0 |
| 2026-07-27 | Lechleider Robert | Chief Medical Officer | Buy | 54,000 | $0 |
| 2026-07-27 | Tsai Philip | Chief Technical Officer | Buy | 38,250 | $0 |
| 2026-07-27 | Rosett Max | Chief Financial Officer | Buy | 47,250 | $0 |
| 2026-07-09 | Horn Kinney | CHIEF BUSINESS OFFICER | Buy | 1,092 | $14,109 |
| 2026-07-09 | Horn Kinney | CHIEF BUSINESS OFFICER | Sell | 1,092 | $27,300 |
| 2026-07-07 | Lechleider Robert | Chief Medical Officer | Sell | 16,214 | $369,031 |
| 2026-07-07 | Barchas Isaac | Director | Sell | 83,094 | $2.0M |
| 2026-07-07 | Lechleider Robert | Chief Medical Officer | Buy | 55,000 | $480,150 |
| 2026-07-07 | Barchas Isaac | Director | Sell | 16,906 | $409,125 |
| 2026-07-07 | Lechleider Robert | Chief Medical Officer | Sell | 22,714 | $498,572 |
Source: SEC Form 4 filings · as of 2026-09-15